Cindy Brothers

High Sensitivity of Human Leukocyte Antigen–B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients

Michael S. Saag, Rukmini Balu, Elizabeth J. Phillips et al. · Clinical Infectious Diseases · 2008 · 431 citations · Full text

Life Sciences, Dermatology, Immunology +12

Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial

Jan van Lunzen, Franco Maggiolo, José Ramón Arribas et al. · The Lancet Infectious Diseases · 2011 · 298 citations

Pharmacy, Pharmacokinetics, Pharmacotherapy +15

Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects

Cindy Brothers, Jaime E. Hernández, Amy Cutrell et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2009 · 182 citations

Medicine, Cardiology, Pharmacology +15

PREDICT‐1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events

Sara Hughes, Arlene R. Hughes, Cindy Brothers et al. · Pharmaceutical Statistics · 2007 · 53 citations · Full text

Medicine, Molecular Medicine, Pharmacology +17

Long-Term Safety and Tolerability of the Lamivudine/Abacavir Combination as Components of Highly Active Antiretroviral Therapy

Steve A Castillo, Jaime E. Hernández, Cindy Brothers · Drug Safety · 2006 · 17 citations

Medicine, Pharmacokinetics, Pharmacology +15